High importance
Oct 1, 2026
Understanding the mechanistic disruptions caused by SMAD4 mutations is critical for developing targeted therapies for HHT. Identifying c-KIT as a potential therapeutic target could pave the way for novel treatment strategies aimed at mitigating AVMs and improving patient outcomes.
To explore the mechanistic role of SMAD4 in regulating fluid shear stress (FSS) in vascular endothelial cells and its implications for arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia (HHT).
The findings revealed that SMAD4 LOF leads to a reconfiguration of endothelial cells to a lower FSS set point, facilitating characteristics typical of high-FSS remodeling through elevated KLF4 levels and Akt activation. c-KIT was identified as a key regulator in this process, promoting sustained activation of the ERK5/KLF4/Akt signaling pathway.
The study utilized murine and human endothelial cell models with SMAD4 loss-of-function (LOF) mutations to investigate the signaling pathways involved, particularly focusing on the c-KIT receptor and its regulatory effects on KLF4 and Akt activation in relation to FSS set points.
The study primarily focused on in vitro models, which may not fully replicate the in vivo conditions present in patients with HHT. Further research is needed to validate these findings in human subjects and to assess the clinical relevance of targeting c-KIT.
For your doctor:
PMID: 42820305
DOI: 10.1172/JCI197609
Vascular endothelial cells (ECs) encode a homeostatic fluid shear stress (FSS) set point that is essential for vascular stability. Deviations above or below this threshold trigger adaptive remodeling to restore physiological shear levels. Disruption of this control mechanism leads to enlarged arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia, a vascular disorder caused by heterozygous loss-of-function (LOF) mutation in ALK1, ENG, or SMAD4. Mechanistically, Smad4-deficient ECs are reset to a lower FSS set point value, resulting in AVMs that show characteristics of high-FSS remodeling with elevated KLF4 and high activation of the downstream Akt. Here, we investigated the KLF4/Akt upstream mechanisms by which SMAD4 sets the physiological FSS set point. We identified the receptor tyrosine kinase c-KIT as a component and regulator of the junctional mechanosensory receptor complex, which is highly upregulated in murine and human AVMs. SMAD4 restrains flow signaling by limiting c-KIT-dependent ERK5 activation and KLF4 induction. Thus, SMAD4 LOF leads to sustained c-KIT engagement in the sensory junctional apparatus, driving enhanced and prolonged activation of the ERK5/KLF4/Akt signaling axis. These results show that Smad4-LOF mutations induce malformations by disabling a key homeostatic mechanism and identify c-KIT as a potentially previously unrecognized therapeutic target.